摘要
目的:探讨微创颅内血肿清除术治疗重症高血压脑出血的临床疗效。方法:从笔者所在医院收治的高血压脑出血患者中随机抽取120例,并将其随机均分为治疗组和对照组,治疗组60例采取微创颅内血肿清除术治疗,对照组60例采取传统开颅术治疗。术后3个月,观察两组患者疗效。结果:治疗组存活率达76.67%,对照组为56.67%,两组比较差异有统计学意义(P<0.01)。治疗半个月、1个月后治疗组存活患者的神经功能缺损评分分别为(18.4±4.0)分、(13.8±3.8)分;对照组分别为(27.2±5.1)分、(24.3±5.0)分,两组比较差异有统计学意义(P<0.05)。结论:颅内血肿微创清除术具有安全简便、定位准确、存活率高、并发症少等优点,疗效显著,是治疗重症高血压脑出血的一种较好的方法,值得临床推广应用。
Objective ：To explore the clinical efficacy of minimally invasive intracranial hematoma surgery for severe hypertension cerebral hemorrhage. Methods ：Randomly distilled 120 cases of patients from hypertensive intracerebral hemorrhage admitted in our hospital, and randomly and average divided into the treatment group and the control group, 60 cases of patients of the treatment group took minimally invasive hematoma evacuation surgery, the control group took traditional craniotomy surgery, 3 months after treatment, observed the efficacy of two groups.Results ：The survival rate of the treatment group was 76.67%, the control group was 56.67%, the difference of two groups compared was significant（P〈0.01）.Half months, 1 months after treatment, neurological deficit score of survival patients of the treatment group were （18.4 ± 4.0）, （13.8 ± 3.8）, the control group were （27.2 ± 5.1）, （24.3 ± 5.0）, the difference of two groups compared were significant（P〈0.05）.Conclusion ：Invasive hematoma evacuation surgery is with the advantage of safe, simple, accurate positioning, high survival rate and fewer complications etc, the efficacy is notable, is a good method for the treatment of severe hypertensive intraeerebral hemorrhage, worthy of clinical promotion and application.
出处
《中外医学研究》
2012年第17期15-16,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
微创颅内血肿清除术
高血压
脑出血
Minimally invasive bematoma evacuation surgery
Hypertension
Cerebral hemorrhage
